FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy ...Middle East

Medscape - News
FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy
The FDA has approved a supplemental new drug application for the treatment of cardiomyopathy wild-type or hereditary transthyretin-mediated amyloidosis. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy )

Also on site :